ArticleTherapeutic innovation & regulatory science2024
Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology.
Akio Maki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it